Neurocrine Bioscience buy Bank of America Co.
Start price
07.02.25
/
50%
€125.40
Target price
07.02.26
€172.66
Performance (%)
-5.94%
End price
08.02.26
€117.95
Summary
This prediction ended on 08.02.26 with a price of €117.95. With a performance of -5.94%, the BUY prediction for Neurocrine Bioscience by Bank_of_America_Co_ closed slightly in the red. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 0.629% | 0.629% | 25.729% |
| iShares Core DAX® | 0.411% | 8.821% | 12.264% |
| iShares Nasdaq 100 | 3.678% | 10.820% | 44.017% |
| iShares Nikkei 225® | 2.701% | 15.247% | 48.041% |
| iShares S&P 500 | 2.445% | 7.933% | 32.998% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at Bank of America Co. from $184.00 to $179.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten